Switzerland has established itself as a global leader in the biotech industry, making significant advancements in areas such as cancer treatment, immunotherapy, gene and cell therapy, and more. With a strong focus on personalized and precision medicine, the Swiss biotech sector thrives on
Synthetic biology, commonly known as synbio, is at the cutting edge of biotechnology, offering revolutionary solutions for various industries. Dr. John Cumbers, a pioneering figure in this field and the Founder and CEO of SynBioBeta LLC, provides profound insights into how synbio can address
The dawn of a food revolution is upon us, with synthetic biology at the helm, ready to address critical issues like resource scarcity and population growth. The anticipated SynBioBeta 2024's food and ag panel sessions are likely to showcase significant advances in synthetic biology, signaling
Synthetic biology stands at the vanguard of biotechnology, offering a future where the creation and manipulation of life are not confined to the boundaries of natural evolution. Unlike traditional gene editing, which typically involves small-scale modifications, synthetic biology ambitiously seeks
The fusion of synthetic biology (SynBio) with architecture is marking the beginning of a revolutionary shift towards eco-friendly building methods. At the forefront is Ginger Dosier with her pioneering company, Biomason; she represents the future of green construction. SynBio's integration
Synthetic biology stands at the forefront of modern science, with gene therapy being one of its most exciting horizons. The ability to control gene expression within mammalian cells holds enormous potential for treating a myriad of diseases. However, achieving precise and robust inducible gene
